West Pharmaceutical Services (WST) Stock Forecast & Price Target $221.45 -2.43 (-1.09%) As of 01:15 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Analyst Forecasts Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock West Pharmaceutical Services - Analysts' Recommendations and Stock Price Forecast (2025) How MarketBeat Calculates Price Target and Consensus Rating MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data. Consensus Rating Moderate BuyBased on 7 Analyst RatingsSell0Hold1Buy6 Based on 7 Wall Street analysts who have issued ratings for West Pharmaceutical Services in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 7 analysts, 1 has given a hold rating, and 6 have given a buy rating for WST. Consensus Price Target $332.5050.15% Upside According to the 7 analysts' twelve-month price targets for West Pharmaceutical Services, the average price target is $332.50. The highest price target for WST is $400.00, while the lowest price target for WST is $250.00. The average price target represents a forecasted upside of 50.15% from the current price of $221.45. Get the Latest News and Ratings for WST and Related Stocks Enter your email address to receive the latest news and analysts' ratings for West Pharmaceutical Services and its competitors. Enter your email to sign up for newsletter Sign Up WST Analyst Ratings Over TimeTypeCurrent Forecast4/1/24 to 4/1/251 Month Ago3/2/24 to 3/2/253 Months Ago1/2/24 to 1/1/251 Year Ago4/2/23 to 4/1/24Strong Buy0 Strong Buy rating(s)0 Strong Buy rating(s)0 Strong Buy rating(s)0 Strong Buy rating(s)Buy6 Buy rating(s)5 Buy rating(s)4 Buy rating(s)4 Buy rating(s)Hold1 Hold rating(s)1 Hold rating(s)1 Hold rating(s)1 Hold rating(s)Sell0 Sell rating(s)0 Sell rating(s)0 Sell rating(s)0 Sell rating(s)Consensus Price Target$332.50$344.00$437.75$435.20Forecasted Upside50.15% Upside48.00% Upside33.64% Upside9.92% UpsideConsensus RatingModerate BuyModerate BuyModerate BuyModerate Buy Remove Ads WST Analyst Recommendations By MonthAnalyst Ratings Chart DescriptionThe chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.Skip Chart & View Analyst Rating History WST Price Targets by MonthAverage Share Price and Price Target by Month Chart DescriptionThe chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table West Pharmaceutical Services Stock vs. The CompetitionTypeWest Pharmaceutical ServicesMedical CompaniesS&P 500Consensus Rating Score 2.86 2.82 2.54Consensus RatingModerate BuyModerate BuyModerate BuyPredicted Upside48.47% Upside19,365.72% Upside19.04% UpsideNews Sentiment RatingPositive NewsSee Recent WST NewsPositive NewsPositive News Remove Ads Recent Analyst Forecasts and Stock Ratings All Ratings Strong Buy Buy Hold Sell Rating Show All Upside > 100% Upside 50% - 100% Upside 20% - 50% Upside 10% - 20% Upside 0% - 10% Downside 0% - 10% Downside 10% - 20% Downside 20% - 50% Downside 50% - 100% Downside > 100% Upside/Downside All Actions Upgrades Downgrades Initiates Coverage Raises Target Lowers Target Reiterates Rating Action Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Years 5 Years Time Frame Start Date End Date Most Recent from Each Brokerage All Show Export to Excel DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails3/18/2025Evercore ISI2 of 5 starsDaniel MarkowitzSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageOutperform$275.00+18.74%2/14/2025KeyCorp3 of 5 starsPaul KnightSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower TargetOverweight ➝ Overweight$470.00 ➝ $325.00+46.46%2/14/2025Deutsche Bank Aktiengesellschaft3 of 5 stars UpgradeHold ➝ Buy$250.00+25.38%1/8/2025CitigroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingP. DonnellySubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageBuy$400.00+20.24%12/13/2024Bank of AmericaSubscribe to MarketBeat All Access for the recommendation accuracy rating Boost TargetBuy ➝ Buy$350.00 ➝ $355.00+8.95%12/13/2024Wolfe ResearchSubscribe to MarketBeat All Access for the recommendation accuracy ratingD. SchenkelSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoveragePeer Perform12/12/2024UBS GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingJ. SourbeerSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeNeutral ➝ Buy$350.00 ➝ $390.00+22.63%2/7/2024Jefferies Financial GroupSubscribe to MarketBeat All Access for the recommendation accuracy rating UpgradeHold ➝ Buy$323.00 ➝ $536.00+34.58%10/27/2023StephensSubscribe to MarketBeat All Access for the recommendation accuracy rating Lower TargetOverweight ➝ Overweight$420.00 ➝ $390.00+20.06%Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Tuesday at 01:15 PM ET. Should I Buy West Pharmaceutical Services Stock? WST Pros and Cons Explained These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Monday, March 31, 2025. Please send any questions or comments about these West Pharmaceutical Services pros and cons to contact@marketbeat.com. West Pharmaceutical Services Bull Case Here are some ways that investors could benefit from investing in West Pharmaceutical Services, Inc.: Recent earnings report showed a strong performance with an EPS of $1.82, exceeding the consensus estimate of $1.75, indicating robust financial health. The stock has a current price of $223.95, which is significantly lower than its 52-week high of $396.75, suggesting potential for price appreciation. West Pharmaceutical Services, Inc. has a market capitalization of approximately $16.19 billion, reflecting its strong position in the medical instruments sector. Analysts have a consensus rating of "Moderate Buy" with an average price target of $332.50, indicating positive sentiment and potential upside for investors. The company has a low debt-to-equity ratio of 0.08, suggesting strong financial stability and lower risk for investors. West Pharmaceutical Services Bear Case Investors should be bearish about investing in West Pharmaceutical Services, Inc. for these reasons: Despite the positive earnings, the stock has experienced significant volatility, with a 52-week low of $197.01, which may concern risk-averse investors. The company has a high PE ratio of 33.47, which may indicate that the stock is overvalued compared to its earnings, potentially deterring value investors. Recent downgrades from analysts, including a shift from "buy" to "hold" by StockNews.com, may signal caution regarding future performance. The dividend yield is relatively low at 0.38%, which may not attract income-focused investors looking for higher returns. Market conditions and competition in the healthcare sector could impact future growth, making it a riskier investment in the current environment. WST Forecast - Frequently Asked Questions What is West Pharmaceutical Services' forecast for 2025? According to the research reports of 7 Wall Street equities research analysts, the average twelve-month stock price forecast for West Pharmaceutical Services is $332.50, with a high forecast of $400.00 and a low forecast of $250.00. Should I buy or sell West Pharmaceutical Services stock right now? 7 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for West Pharmaceutical Services in the last twelve months. There is currently 1 hold rating and 6 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" WST shares. Does West Pharmaceutical Services's stock price have much upside? According to analysts, West Pharmaceutical Services's stock has a predicted upside of 50.15% based on their 12-month stock forecasts. Has West Pharmaceutical Services been upgraded by Wall Street analysts recently? Over the previous 90 days, West Pharmaceutical Services's stock had 1 upgrade by analysts. What analysts cover West Pharmaceutical Services? West Pharmaceutical Services has been rated by research analysts at Citigroup, Deutsche Bank Aktiengesellschaft, Evercore ISI, and KeyCorp in the past 90 days. Do Wall Street analysts like West Pharmaceutical Services more than its competitors? Analysts like West Pharmaceutical Services more than other "medical" companies. The consensus rating score for West Pharmaceutical Services is 2.86 while the average consensus rating score for "medical" companies is 2.82. Learn more on how WST compares to other companies. Stock Forecasts and Research Tools Related Companies Cooper Companies Stock Forecast Align Technology Stock Forecast Merit Medical Systems Stock Forecast ICU Medical Stock Forecast Haemonetics Stock Forecast DENTSPLY SIRONA Stock Forecast QuidelOrtho Stock Forecast Neogen Stock Forecast STAAR Surgical Stock Forecast Cerus Stock Forecast Today's Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter This page (NYSE:WST) was last updated on 4/1/2025 by MarketBeat.com Staff From Our PartnersNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredRetirement Nightmare? It’s Already Happening.The market is on edge. Every day, another company slashes its dividend, leaving investors scrambling. Intel...Investors Alley | SponsoredNew “Trump” currency proposed in DCA former U.S. Presidential Advisor has come forward with a stern warning to investors: “Get out of tech, no...Paradigm Press | SponsoredA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | Sponsored10X Bigger than AI, quantum, EVs, crypto, and robotics combined?World Economic Forum: "Arguably the Most Exciting Human Discovery Since Fire" Sam Altman, Bill Gates, and M...Stansberry Research | SponsoredIs Fort Knox Hiding Less Gold Than We Think? Find Out What That Means for YouWith gold prices recently soaring to record highs over $3,000 an ounce, and central banks rushing to accumulat...The Oxford Club | SponsoredLive Footage From Elon Musk’s “Area 51”What’s happening inside this nondescript building in South Memphis is so incredible… That Elon’s competitor...Brownstone Research | SponsoredTermination: 18F (read immediately)Have you ever heard of the government's 18F program? It helped manage digital services across the governmen...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding West Pharmaceutical Services, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share West Pharmaceutical Services With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy WST Stock Free WST Stock Alerts